Age-Related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine

Journal of Infectious Diseases

Volumn 171, Issue 1, 1995, Pages 13-17

  Nader, Sonia ^a   Bergen, Randy ^a   Sharp, Margaret ^a   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ADULT; ARTICLE; CELLULAR IMMUNITY; CHICKENPOX; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEROCONVERSION; T LYMPHOCYTE; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNIZATION SCHEDULE; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TIME FACTORS; VACCINATION; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 0028893033     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/171.1.13     Document Type: Article

References (26)

1. Whitley RJ. Varicella-zoster virus. In: Galasso G, Whitley R. Merigan TC, eds. Antiviral agents and viral diseases of man. New York: Raven Press. 1990:235-64
2. Arbeter AM, Starr SE, Weibel RE. Plotkin SA. Varicella vaccine studies in healthy children and adults. Pediatrics 1986;78 (suppl):748-56
3. Gershon AA, Steinberg SP, LaRussa P, Ferrara A, Hammerschlag M. Gelb L. Immunization of healthy adults with live attenuated varicella vaccine. J Infect Dis 1988:158:132-7
4. Brunell PA, Novelli VM, Lipton SV, Pollock B. Combined vaccine against measles, mumps, rubella, and varicella. Pediatrics 1988;81:779-84
5. Johnson CE, Shurin PA, Fattlar D, Rome LP. Kumar ML. Live attenuated varicella vaccine in healthy 12- to 24-month-old children. Pediatrics 1988;81:512-8
6. Gershon AA. Varicella vaccine: the American experience. J Infect Dis 1992;166(suppI l):63-8
7. Arvin AM, Koropchak CM, Williams BRG, Grumet FC, Foung SK. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 1986;154:422-9
8. Patel PA. Yoonessi S. O'Malley J, Freeman A, Gershon A, Ogra PL. Cell-mediated immunity to varicella zoster virus infection in subjects with lymphoma or leukaemia. J Pediatr 1979;94:223-30
9. Meyers JD, Flournoy N, Thomas ED. Cell-mediated immunity to varicella-zoster virus after allogeneic marrow transplant. J Infect Dis 1980;141:479-87
10. Hayward AR. T cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV. J Virol 1990;64:651-5
11. Weibel RE, Kuter BJ, Neff BJ, et al. Live Oka/Merck varicella vaccine in healthy children. Further clinical and laboratory assessment. JAMA 1985;254:2435-9
12. Bergen RE, Diaz PS, Arvin AM. The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content. J Infect Dis 1990;162:1049-54
13. Watson B, Keller PM, Ellis RW. Starr SE. Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: kinetics and specificity. J Infect Dis 1990; 162:794-9
14. Giller RH, Winstorfer S, Grose C. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects. J Infect Dis 1989;160:919-28
15. White CJ, Kuter BJ, Ngai A, et al. Modified cases of chickenpox after varicella vaccination: correlation of protection with antibody response. Pediatr Infect Dis J 1992; 11:19-23
16. Gershon AA, Steinberg SP, Gelb L., et al. Live attenuated varicella vaccine: efficacy for children with leukemia in remission. JAMA 1984;252:355-62
17. Gershon AA, Steinberg SP. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine. N Engl J Med 1989;320:892-7
18. Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR. The immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis 1992;166:253-9
19. Hardy IB, Gershon AA, LaRussa PS, Steinberg SP. The incidence of zoster after immunization with live attenuated varicella vaccine: a study in children with leukemia. N Engl J Med 1991;325:1545-50
20. Berger, R. Luescherm D, Just M. Enhancement of varicella zoster specific immune responses in the elderly by boosting with varicella vaccine. J Infect Dis 1984;149:647-52
21. Miller RA. Aging and immune function. Int Rev Cytol 1991; 124:187-94
22. Thoman ML, Weigle WO. The cellular and subcellular bases of im-munosenescence. Adv Immunol 1989;46:221-37
23. Hobbs MV, Weigle WO, Noonan DJ, et al. Patterns of cyotokine gene expression by CD4+ T cells from young and old mice. J Immunol 1993;150:3602-14
24. Miller AE. Selective decline in cellular immune response to varicella zoster in the elderly. Neurology 1980;30:582-7
25. Berger R, Florent G. Just M. Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged. Infect Immun 1981;32:24-7
26. Hayward AR, Herberger M. Lymphocyte responses to varicella-zoster virus in the elderly. J Clin Immunol 1987;7:174-8